• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Gastrointestinal Stromal Tumors

Gastrointestinal Stromal Tumors - 31 Studies Found

Recruiting : Study of Tumor Samples in Patients Undergoing Treatment for Gastrointestinal Stromal Tumors on Clinical Trial ACOSOG-Z9001
: Gastrointestinal Stromal Tumor
: 2009-08-06
:
  • Genetic: mutation analysis
  • Genetic: polymo

Terminated : Imatinib Mesylate and Sunitinib in Treating Patients With Gastrointestinal Stromal Tumors
: Gastrointestinal Stromal Tumor
: 2007-12-13
:
  • Drug: imatinib mesylate will s

Completed : S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors
: Gastrointestinal Stromal Tumor
: 2000-05-02
: Drug: temozolomide 200 mg/m^2/day, PO, on Days 1-5 of each 28 day cycle.
Completed : Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor
: Gastrointestinal Stromal Tumor
: 2005-06-02
:
  • Drug: imatinib mesylate
  • Procedure: convent

Active, not recruiting : Dasatinib as First-Line Therapy in Treating Patients With Gastrointestinal Stromal Tumors
: Gastrointestinal Stromal Tumor
: 2007-12-05
: Drug: dasatinib Dasatinib is given orally 70 mg BID. Dasatinib will be continued until progression, unac
Terminated : Imatinib Mesylate With or Without Surgery in Treating Patients With Metastatic Gastrointestinal Stromal Tumor That is Responding to Imatinib Mesylate
: Gastrointestinal Stromal Tumor
: 2009-08-08
:
  • Drug: imatinib mesylate Patien

Terminated : Imatinib Mesylate in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumor
: Gastrointestinal Stromal Tumor
: 2008-05-22
: Drug: imatinib mesylate By mouth
Terminated : Imatinib Mesylate or Observation Only in Treating Patients Who Have Undergone Surgery for Localized Gastrointestinal Stromal Tumor
: Gastrointestinal Stromal Tumor
: 2005-02-07
:
  • Drug: imatinib mesylate
  • Procedure: adjuvan

Active, not recruiting : A Study of Famitinib in Patients With Gastrointestinal Stromal Tumor
: Gastrointestinal Stromal Tumor
: 2015-01-08
: Drug: Famitinib
Completed : Open-label Trial of GlivecWith Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumors
: Gastrointestinal Stromal Tumors
: 2006-02-16
: Drug: Glivec 400mg p.o./day in a population of patients with locally advanced (=not amenable to surgery
Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.